down arrow

Shaanxi Meibang Pharmaceutical Group Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: CNE100005071
CNY
21.04
-0.76 (-3.49%)

Dec 16

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Shaanxi Meibang Pharmaceutical Group Co., Ltd.
Why is Shaanxi Meibang Pharmaceutical Group Co., Ltd. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
  • Poor long term growth as Net Sales has grown by an annual rate of -6.63% and Operating profit at -76.23% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
  • The company has been able to generate a Return on Equity (avg) of 7.87% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -6.63% and Operating profit at -76.23% over the last 5 years
3
Flat results in Mar 25
  • ROCE(HY) Lowest at 1.93%
  • DEBT-EQUITY RATIO (HY) Highest at -21.5 %
  • PRE-TAX PROFIT(Q) Fallen at -37.24%
4
With ROE of 1.90%, it has a very expensive valuation with a 0.64 Price to Book Value
  • Over the past year, while the stock has generated a return of 63.27%, its profits have fallen by -33.2%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shaanxi Meibang Pharmaceutical Group Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Shaanxi Meibang Pharmaceutical Group Co., Ltd.
-100.0%
1.16
66.37%
China Shanghai Composite
14.03%
0.86
14.45%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-6.63%
EBIT Growth (5y)
-76.23%
EBIT to Interest (avg)
60.71
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
0.64
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
53.19%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.59%
ROE (avg)
7.87%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
34
Industry P/E
Price to Book Value
0.64
EV to EBIT
205.40
EV to EBITDA
25.42
EV to Capital Employed
0.54
EV to Sales
0.57
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.26%
ROE (Latest)
1.90%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
NET SALES(HY)

At CNY 549.47 MM has Grown at 20.71%

RAW MATERIAL COST(Y)

Fallen by -9.31% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 2.64%

DEBTORS TURNOVER RATIO(HY)

Highest at 3.81%

-9What is not working for the Company
ROCE(HY)

Lowest at 1.93%

DEBT-EQUITY RATIO (HY)

Highest at -21.5 %

PRE-TAX PROFIT(Q)

Fallen at -37.24%

NET PROFIT(Q)

Fallen at -32.6%

Here's what is working for Shaanxi Meibang Pharmaceutical Group Co., Ltd.
Net Sales
At CNY 549.47 MM has Grown at 20.71%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Inventory Turnover Ratio
Highest at 2.64%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio
Highest at 3.81%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -9.31% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shaanxi Meibang Pharmaceutical Group Co., Ltd.
Pre-Tax Profit
Fallen at -37.24%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit
Fallen at -32.6%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is negative

Net Profit (CNY MM)

Debt-Equity Ratio
Highest at -21.5 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."